Histone Arg modifications and p53 regulate the expression of OKL38, a mediator of apoptosis - Wikidata - awgldk - TriplyDB

Histone Arg modifications and p53 regulate the expression of OKL38, a mediator of apoptosis

Histone Arg modifications and p53 regulate the expression of OKL38, a mediator of apoptosis

http://www.wikidata.org/entity/Q39979219

about

Discovery of peptidylarginine deiminase-4 substrates by protein array: antagonistic citrullination and methylation of human ribosomal protein S2 Peptidylarginine deiminase and protein citrullination in prion diseases: strong evidence of neurodegeneration The development of N-α-(2-carboxyl)benzoyl-N(5)-(2-fluoro-1-iminoethyl)-l-ornithine amide (o-F-amidine) and N-α-(2-carboxyl)benzoyl-N(5)-(2-chloro-1-iminoethyl)-l-ornithine amide (o-Cl-amidine) as second generation protein arginine deiminase (PAD) i Synthesis and Screening of a Haloacetamidine Containing Library To Identify PAD4 Selective Inhibitors Interaction of OKL38 and p53 in regulating mitochondrial structure and function Potential role for PAD2 in gene regulation in breast cancer cells.Hepatic gene expression profiling of 5'-AMP-induced hypometabolism in mice Investigating citrullinated proteins in tumour cell lines Increased PADI4 expression in blood and tissues of patients with malignant tumors Genome-wide analysis reveals PADI4 cooperates with Elk-1 to activate c-Fos expression in breast cancer cells.Citrullination of DNMT3A by PADI4 regulates its stability and controls DNA methylation Expression of peptidylarginine deiminase type 4 in ovarian tumors.A fluopol-ABPP HTS assay to identify PAD inhibitors.Potential role for PADI-mediated histone citrullination in preimplantation development Citrullination of histone H3 interferes with HP1-mediated transcriptional repression.Identification of PADI2 as a potential breast cancer biomarker and therapeutic target.N-α-benzoyl-N5-(2-chloro-1-iminoethyl)-L-ornithine amide, a protein arginine deiminase inhibitor, reduces the severity of murine collagen-induced arthritis.Autodeimination of protein arginine deiminase 4 alters protein-protein interactions but not activity.Investigating the pathogenic role of PADI4 in oesophageal cancer Inhibiting protein arginine deiminases has antioxidant consequences.Chemical biology of protein arginine modifications in epigenetic regulation Peptidylarginine deiminase type 4 deficiency reduced arthritis severity in a glucose-6-phosphate isomerase-induced arthritis model.Identification of novel NRF2-regulated genes by ChIP-Seq: influence on retinoid X receptor alpha.Potential role of peptidylarginine deiminase enzymes and protein citrullination in cancer pathogenesis.Activation of PAD4 in NET formation.Activation of apoptosis in NAF-1-deficient human epithelial breast cancer cells Protein Arginine Methylation and Citrullination in Epigenetic Regulation A novel PAD4/SOX4/PU.1 signaling pathway is involved in the committed differentiation of acute promyelocytic leukemia cells into granulocytic cells Dysregulation of PAD4-mediated citrullination of nuclear GSK3β activates TGF-β signaling and induces epithelial-to-mesenchymal transition in breast cancer cells.Histone hypercitrullination mediates chromatin decondensation and neutrophil extracellular trap formation.Protein arginine deiminase 4 (PAD4): Current understanding and future therapeutic potential Role of peptidylarginine deiminase type 4 in gastric cancer.PADI4 has genetic susceptibility to gastric carcinoma and upregulates CXCR2, KRT14 and TNF-α expression levels.The cell death machinery governed by the p53 tumor suppressor in response to DNA damage.PADI4 Epigenetically Suppresses p21 Transcription and Inhibits Cell Apoptosis in Fibroblast-like Synoviocytes from Rheumatoid Arthritis Patients.Opposite effects of HDAC5 and p300 on MRTF-A-related neuronal apoptosis during ischemia/reperfusion injury in rats.The protein arginine deiminases: Structure, function, inhibition, and disease.Insights into the mechanism of streptonigrin-induced protein arginine deiminase inactivation A novel role for peptidylarginine deiminases in microvesicle release reveals therapeutic potential of PAD inhibition in sensitizing prostate cancer cells to chemotherapy.A novel role for protein arginine deiminase 4 in pluripotency: the emerging role of citrullinated histone H1 in cellular programming.

P2860

Q24303513-66AB0E3C-AED0-4700-B478-821179C87E20 Q27023431-EA7DAB1F-3AB0-4125-8749-75040984E608 Q27672732-062BAF21-437E-402E-8677-E30CC66037D2 Q27675108-D8EDC534-6171-4F37-9EF8-2FF6D7104449 Q28482351-6D4ECA52-B76B-4311-B490-B146051652F3 Q28728858-BD1E4856-6F1B-4619-A4F3-08FCD0FBBCFA Q30500190-2F0BC922-AA74-4256-9524-FC9114032D38 Q31140984-B0CDE969-9870-4C4F-A939-ADC6E433244B Q33404427-9EBDA1A5-6D48-4762-99F6-DCD033910D9A Q33926858-349F4B9D-C875-4B1F-A6F7-3B72DD865CCA Q33983526-318F0052-7128-4B9D-9E9A-AB7482897F9F Q34111421-01BC9585-4414-4EF3-B2EC-F79EFD847117 Q34143238-5A1AE744-210D-439D-97ED-BC51873C1AF7 Q34308802-810BE164-13A9-4A88-9848-19C64FFD840F Q34426561-6505C1ED-A891-4F1F-A685-4095BB4ACBB6 Q34461456-18CF6E73-5BDA-446F-80DA-2988B2D6D02D Q34904630-67525A2E-D287-491E-94C6-D7033611D80D Q34969938-0359C8AA-F0F3-48BC-AC7A-D073643B0AFD Q35059255-F212AAB2-41C8-4320-96D6-B97259775012 Q35197879-BCC9AACA-CAFA-4016-9380-9D4CE07C428D Q35722457-3917081F-B951-407A-A18F-44949D610DF3 Q35979391-DACAFA40-3BE1-4D21-B3C0-AA62DA91BF1D Q36180243-62B0878A-686C-489F-8261-D58A4D1CC391 Q36277576-E8536766-F212-4520-A0CA-967A939BF038 Q36474561-ED7E1382-2C5D-4138-BD21-FA4D6FB44FC6 Q36518614-E06A3CE4-6300-4F05-9A05-88C3CAA5370B Q36713555-9F815A01-E854-4C8C-9235-8EA6E6069F39 Q36772066-FF383528-BFCB-4D99-B528-72EC45EE1B6D Q37031694-521A4012-34E4-4EE9-BD84-9D89313EBE01 Q37124853-5EDCA55C-A818-455D-A18C-F19969EA278E Q37165601-28AFEE4D-09A2-4223-A7F6-E85524273E2A Q37406509-938AD01E-FF98-41A0-B752-947E292E9B17 Q37641748-2FCAA45A-2B17-4124-B19D-984FF26F147E Q37687474-2D5BDFE6-BAE5-4FCA-97FA-D9F9D5C564FF Q37726242-89DD930A-68F8-46EB-8612-45342892FEDB Q37745161-631B2F8C-572A-46B8-88E0-D1DD980B66A6 Q38061870-1EDEBACF-FA4A-47BC-9FB3-BB01C04B3131 Q38280544-94C273A0-BDD8-4E1C-90C6-68DE68E88B89 Q38443364-E4584383-FC7A-4CD0-8003-A14A2A998717 Q38449033-FB5951AE-5FEB-4DA4-B049-A6F0D676B307

P2860

Histone Arg modifications and p53 regulate the expression of OKL38, a mediator of apoptosis

http://www.wikidata.org/entity/Q39979219

description

2008 nî lūn-bûn

@nan

2008年の論文

@ja

2008年学术文章

@wuu

2008年学术文章

@zh-cn

2008年学术文章

@zh-hans

2008年学术文章

@zh-my

2008年学术文章

@zh-sg

2008年學術文章

@yue

2008年學術文章

@zh

2008年學術文章

@zh-hant

name

Histone Arg modifications and ...... OKL38, a mediator of apoptosis

@en

Histone Arg modifications and ...... KL38, a mediator of apoptosis.

@nl

type

label

Histone Arg modifications and ...... OKL38, a mediator of apoptosis

@en

Histone Arg modifications and ...... KL38, a mediator of apoptosis.

@nl

prefLabel

Histone Arg modifications and ...... OKL38, a mediator of apoptosis

@en

Histone Arg modifications and ...... KL38, a mediator of apoptosis.

@nl

P1433

Q39979219-7B0E700A-71B5-49DD-9818-C86C497EB534

P1476

Q39979219-E321BFFE-9FED-4796-8552-AB947CC38191

P2093

Q39979219-16771E77-BA80-4030-846A-D3DE86801927

Q39979219-2949455F-EB76-440B-8A9E-A856857E75DE

Q39979219-5B469BE9-2E10-413C-8A90-1285E38E0A7B

Q39979219-614C0B74-6875-4458-94F8-A3C6D6EA2AE1

Q39979219-6E44831E-26F7-46A7-836A-4DA7283F1728

Q39979219-7EB4FE9D-A936-4D0B-881A-50E968207576

Q39979219-E2BB4070-AE71-4E2A-B61B-BA718CFB5912

P2860

Q39979219-09632510-C505-4745-9518-775E981510A1

Q39979219-0B2D4438-7164-45FD-9801-164510A23217

Q39979219-1B3AFBBC-DF22-4C11-A85F-D75BBC8750B9

Q39979219-1DDB3FBA-9A39-4624-8225-F6DD3829E350

Q39979219-2BB7760D-C7C2-401E-ABB9-0C513E616AC3

Q39979219-38BC0EA7-8F30-436C-B818-A1AE3CC0F326

Q39979219-4E602DF8-5CEC-403E-BAAD-B4A8C5E0F1FF

Q39979219-58122EC4-F00E-4F11-BA62-F5164D6779FF

Q39979219-5B2CB2EF-312C-4BB6-87F9-2E3D40D30C73

Q39979219-5DF0EFAA-7017-43AD-A884-628F6CB2D2DA

P304

Q39979219-10A19079-AC83-4DA6-99E0-4707AAB87EA6

P31

Q39979219-E4ACC79E-935B-4C29-95BB-7C442D1F61AE

P356

Q39979219-0B1536FC-90DC-4389-8B21-D81DAD24BC2F

P407

Q39979219-5A69A64B-432E-424C-AED2-209AACE18D0E

P433

Q39979219-81CE23B1-6510-4671-9947-26A97A1434A1

P478

Q39979219-A2F1F5E2-8AF1-4723-A8D6-729E9EE19516

P577

Q39979219-11B7BCA7-EE45-4F51-9566-6E27D96B4ECA

P698

Q39979219-879B68EC-8836-446D-B3D4-5D53863B3B66

P921

Q39979219-F73CF901-B642-47A4-9824-37F96DBF5EA9

P932

Q39979219-68D5C11E-1AE1-48A6-9C95-1AD1A25F0F44

P356

P1433

Journal of Biological Chemistry

P1476

Histone Arg modifications and ...... OKL38, a mediator of apoptosis

@en

P2093

B Franklin Pugh

http://www.w3.org/2001/XMLSchema#string

Bryan J Venters

http://www.w3.org/2001/XMLSchema#string

Hongjie Yao

http://www.w3.org/2001/XMLSchema#string

Paul R Thompson

http://www.w3.org/2001/XMLSchema#string

Pingxin Li

http://www.w3.org/2001/XMLSchema#string

Suting Zheng

http://www.w3.org/2001/XMLSchema#string

Yanming Wang

http://www.w3.org/2001/XMLSchema#string

P2860

p53AIP1, a potential mediator of p53-dependent apoptosis, and its regulation by Ser-46-phosphorylated p53

Cloning and characterization of a novel pregnancy-induced growth inhibitor in mammary gland

Histone deimination antagonizes arginine methylation

Methylation at arginine 17 of histone H3 is linked to gene activation

The language of covalent histone modifications

The role of chromatin during transcription

Surfing the p53 network

TIGAR, a p53-inducible regulator of glycolysis and apoptosis

Regulation of transcription by a protein methyltransferase

Noxa, a BH3-only member of the Bcl-2 family and candidate mediator of p53-induced apoptosis

P304

20060-20068

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1074/JBC.M802940200

http://www.w3.org/2001/XMLSchema#string

P407

P433

29

http://www.w3.org/2001/XMLSchema#string

P478

283

http://www.w3.org/2001/XMLSchema#string

P577

2008-05-22T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

18499678

http://www.w3.org/2001/XMLSchema#string

P921

apoptotic process

P932

2459274

http://www.w3.org/2001/XMLSchema#string